Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Copernicium Pharmaceuticals Private Limited, is an unlisted private company incorporated on 10 December, 2013. It is classified as a private limited company and is located in , Karnataka. It's authorized share capital is INR 3.60 cr and the total paid-up capital is INR 3.58 cr.
Copernicium Pharmaceuticals's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 1.3% over the previous year. At the same time, it's book networth has increased by 33.12%.
Read more
** All rupee values in INR lacs. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Akash Suresh Puranik
Shareholder
|
06775891 | 12 years |
| Director | Salim Sadiq Shaikh
Shareholder
|
03398407 | 12 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ICICI Bank Limited
No. of Loans: 1
Total Amount : 28.0 cr
HDFC Bank Limited
No. of Loans: 5
Total Amount : 1.2 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| PLAINVIEW PHARMACEUTICALS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| ACTINIC PHARMACEUTICALS PRIVATE LIMITED |
Strike Off
|
1.8 L | 1 | Maharashtra |
| STRIDER LIFESCIENCES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| SEQUENT PENEMS PRIVATE LIMITED |
Active
|
4.5 Cr | 2 | Karnataka |
| VPL CHEMICALS PRIVATE LIMITED |
Active
|
49.9 L | 2 | Karnataka |
| SYMBIO GENERRICS INDIA PRIVATE LIMITED |
Active
|
3.0 Cr | 2 | Karnataka |
| BLUMEN BIOVITALS HEALTHKARE PRIVATE LIMITED |
Active
|
2.7 L | 1 | Maharashtra |
| SYMBIO NATURAL PRODUCTS PRIVATE LIMITED |
Active
|
1.8 L | 2 | Tamil Nadu |
| LAUNCHMYDRUG TECHNOLOGIES PRIVATE LIMITED |
Strike Off
|
27.0 L | 1 | Maharashtra |
| WISERISE VENTURES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
Read more
The incorporation date of COPERNICIUM PHARMACEUTICALS PRIVATE LIMITED is 10 December, 2013
The authorized share capital of COPERNICIUM PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 3.6 Cr.
The paid-up capital of COPERNICIUM PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 3.6 Cr.
The registered address of COPERNICIUM PHARMACEUTICALS PRIVATE LIMITED is Sree Veerabhadreshwara Swamy Enclave, No. 1215, 24th Main, 11th Cross, HSR Layout, 1st S, ector, Bangalore, Bangalore, Karnataka, India, 560102 - 560102
The CIN number of COPERNICIUM PHARMACEUTICALS PRIVATE LIMITED is U24230KA2013PTC072419.